Skip to main content
Premium Trial:

Request an Annual Quote

Genomenon, Limbus Medical to Integrate Technologies for Clinical Variant Interpretation

NEW YORK – Genomenon said Monday that it has partnered with Limbus Medical Technologies to integrate its Mastermind genomics literature search engine into Limbus' Varvis, a genomics-based clinical diagnostics decision support system.

An initial integration now available allows users of Rostock, Germany-based Limbus' Varvis system to preview published articles relevant to their search, but they have to click over to Mastermind to read the articles. The partners said they are in process of creating a deeper link with Mastermind's application programming interface so that full text will be available within Varvis.

"The deep integration of Mastermind into Varvis is a very logical step in the evolution of our products," Limbus Managing Director Ben Liesfeld said in a statement. "It brings the most rapidly growing collection of scientific genomic literature into the patient-centered Varvis cockpit so that the clinician can view all relevant information for this specific patient at a glance."

Genomenon CEO Mike Klein said that the partnership will empower geneticists and researchers to make more informed decisions. "Our relationship extends Mastermind's global reach, and connecting Mastermind with Varvis provides significant value in cutting turnaround time and increasing diagnostic yield for genetic labs," he said.

In February, Ann Arbor, Michigan-based Genomenon reached an agreement with BC Platforms to integrate Mastermind into the BC|Genome genomic interpretation and analysis platform to support molecular diagnostics and other clinical genomics work, as well as into discovery and insight system BC|Insight on the research side.

Less than a month ago, the firm also closed a $5.3 million financing round.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.